{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:55:21Z","timestamp":1761494121539,"version":"build-2065373602"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.hbpd.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T11:27:16Z","timestamp":1703935636000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?"],"prefix":"10.1016","volume":"23","author":[{"given":"Jan","family":"Lerut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1969","series-title":"Experience in liver transplantation","author":"Starzl","key":"10.1016\/j.hbpd.2023.12.001_bib0001"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0748-7983(98)80130-3","article-title":"Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma","volume":"24","author":"Pichlmayr","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0003","first-page":"1567","article-title":"Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?","volume":"23","author":"M\u00fchlbacher","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0004","series-title":"The IASGO textbook of multi-disciplinary management of hepato-pancreato-biliary diseases","first-page":"487","article-title":"Deceased donor liver transplantation: The pendulum of visions and ideas","author":"Lerut","year":"2022"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0006","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms24032358","article-title":"Immunotherapy for hepatocellular carcinoma in the setting of liver transplantation: a review","volume":"24","author":"Lominadze","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101567","article-title":"The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022","volume":"8","author":"Ducreux","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0008","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"Van Cutsem","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0009","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study","volume":"387","author":"Yao","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.soc.2007.04.016","article-title":"Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases","volume":"16","author":"Adam","year":"2007","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJMra065156","article-title":"Strategies for safer liver surgery and partial liver transplantation","volume":"356","author":"Clavien","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jhbp.1248","article-title":"Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis on intention-to-treat outcomes","volume":"30","author":"Di Martino","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4254\/wjh.v7.i15.1899","article-title":"Selection tool alpha-fetoprotein for patients waiting for liver transplantation: how to easily manage a fractal algorithm","volume":"7","author":"Lai","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0016","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0017","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0018","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0019","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s13304-021-01078-4","article-title":"Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score","volume":"73","author":"Lerut","year":"2021","journal-title":"Updates Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/SLA.0b013e3181bd582b","article-title":"Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation","volume":"250","author":"Cherqui","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0021","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamasurg.2021.0954","article-title":"Dynamic \u03b1-fetoprotein response and outcomes after liver transplant for hepatocellular carcinoma","volume":"156","author":"Halazun","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0022","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/lt.23706","article-title":"Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation","volume":"19","author":"Lai","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0023","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000658-199712000-00006","article-title":"Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis","volume":"226","author":"Majno","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0024","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.20837","article-title":"Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma","volume":"12","author":"Otto","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0026","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.3748\/wjg.v24.i37.4230","article-title":"New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma","volume":"24","author":"Lorente","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0039-1677768","article-title":"Alpha-fetoprotein for diagnosis, prognosis, and transplant selection","volume":"39","author":"Trevisani","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0028","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/lt.20642","article-title":"Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma","volume":"12","author":"Takada","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0029","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/lt.21334","article-title":"Extending indication: role of living donor liver transplantation for hepatocellular carcinoma","volume":"13","author":"Todo","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/SLA.0000000000001578","article-title":"Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for hepatocellular carcinoma patients beyond the Milan criteria","volume":"263","author":"Lee","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0031","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jhep.2023.08.020","article-title":"AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation","volume":"79","author":"Norman","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0032","article-title":"Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein","author":"Lai","year":"2023","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0033","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lt.22416","article-title":"Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation","volume":"18","author":"Kornberg","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0034","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jhep.2015.11.033","article-title":"Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation","volume":"64","author":"Hong","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.hbpd.2023.03.010","article-title":"Radiomics in the diagnosis and treatment of hepatocellular carcinoma","volume":"22","author":"Jiang","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RCT.0000000000000476","article-title":"Performance of gadoxetic acid-enhanced liver magnetic resonance imaging for predicting patient eligibility for liver transplantation based on the Milan criteria","volume":"41","author":"Jang","year":"2017","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0037","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.acra.2023.02.035","article-title":"A reliable and repeatable model for predicting microvascular invasion in patients with hepatocellular carcinoma","volume":"30","author":"Tang","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","article-title":"Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches","volume":"14","author":"Sapisochin","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0039","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.3390\/cancers13153657","article-title":"Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma","volume":"13","author":"Lauterio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/TP.0000000000003281","article-title":"Expanding indications of liver transplantation in Spain: consensus statement and recommendations by the Spanish Society of Liver Transplantation","volume":"105","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0041","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.sla.0000171307.37401.db","article-title":"Prognostic impact of anatomic resection for hepatocellular carcinoma","volume":"242","author":"Hasegawa","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0042","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/ajt.13465","article-title":"Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series","volume":"16","author":"Wen","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0043","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nrgastro.2013.194","article-title":"Why does living donor liver transplantation flourish in Asia?","volume":"10","author":"Chen","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0044","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ajt.12907","article-title":"A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients","volume":"15","author":"Lee","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0045","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0046","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.hbpd.2023.10.007","article-title":"Auto-transplantation and ex vivo liver resection as an alternative for the treatment of liver malignancies: Progress and challenges","volume":"23","author":"Yang","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0047","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3748\/wjg.v21.i13.3826","article-title":"Current management of hepatocellular carcinoma: an Eastern perspective","volume":"21","author":"Yim","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0048","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0049","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","article-title":"Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial","volume":"8","author":"Chiang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21037\/hbsn-21-379","article-title":"Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation","volume":"11","author":"Chen","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0051","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/TP.0000000000003162","article-title":"Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging","volume":"104","author":"Soin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0052","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11605-016-3302-0","article-title":"Liver Transplantation after transarterial chemoembolization and radiotherapy for hepatocellular carcinoma with vascular invasion","volume":"21","author":"Jeong","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0053","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hbpd.2020.03.009","article-title":"Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: preliminary experience","volume":"19","author":"Yang","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hbpd.2023.10.002","article-title":"Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?","volume":"23","author":"Bhangui","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1151::AID-CNCR8>3.0.CO;2-V","article-title":"Should hepatomas be treated with hepatic resection or transplantation?","volume":"86","author":"Yamamoto","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0056","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1432-2277.2010.01103.x","article-title":"Liver transplantation and conventional surgery for advanced hepatocellular carcinoma","volume":"23","author":"Hwang","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0057","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/TP.0000000000004593","article-title":"Surgical treatment of hepatocellular carcinoma: multicenter competing-risk analysis of tumor-related death following liver resection and transplantation under an intention-to-treat perspective","volume":"107","author":"Di Sandro","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877107","article-title":"Prognostic factors for 10-year survival in patients with hepatocellular cancer receiving liver transplantation","volume":"12","author":"Lai","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0059","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.hbpd.2020.07.004","article-title":"Combined hepatocellular-cholangiocarcinoma: an update on epidemiology, classification, diagnosis and management","volume":"19","author":"Schizas","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","article-title":"Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS Transplant Oncology Consensus Conference","volume":"104","author":"Sapisochin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0061","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/13651820310020774","article-title":"Split liver transplantation","volume":"6","author":"Broering","year":"2004","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0062","first-page":"e14655","article-title":"Revisiting the forgotten \"full-right full-left\" liver division: Simplified technique and new strategical considerations for clinical implementation in Italy","author":"de Ville de Goyet","year":"2023","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0063","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gtc.2018.01.002","article-title":"Liver transplant for cholangiocarcinoma","volume":"47","author":"Zamora-Valdes","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0064","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0065","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0066","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hbpd.2024.01.003","article-title":"Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma. A critical review","volume":"23","author":"Andraus","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0067","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","article-title":"Combined vascular resection for locally advanced perihilar cholangiocarcinoma","volume":"275","author":"Mizuno","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0068","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? Results from an international benchmark study","volume":"276","author":"Breuer","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0069","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \"very early\" intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0070","doi-asserted-by":"crossref","first-page":"10802","DOI":"10.3389\/ti.2022.10802","article-title":"Outcomes after liver transplantation with incidental cholangiocarcinoma","volume":"35","author":"Safdar","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0071","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0072","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0073","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.hbpd.2023.07.007","article-title":"Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: past, present, and future direction","volume":"23","author":"Kodali","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0074","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/curroncol29050290","article-title":"Gemcitabine and cisplatin as neo-adjuvant for cholangiocarcinoma patients prior to liver transplantation: case-series","volume":"29","author":"Abdelrahim","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hbpd.2019.08.005","article-title":"Secondary non-resectable liver tumors: a single-center living-donor and deceased-donor liver transplantation case series","volume":"18","author":"Lerut","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0076","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study","volume":"257","author":"Le Treut","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0077","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106126","article-title":"Unresectable GIST liver metastases and liver transplantation: a review and theoretical basis for a new indication","volume":"94","author":"Fern\u00e1ndez","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0079","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamasurg.2021.0267","article-title":"Survival outcomes after portal vein embolization and liver resection compared with liver transplant for patients with extensive colorectal cancer liver metastases","volume":"156","author":"Dueland","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0081","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0399-8320(05)80698-0","article-title":"Auxiliary partial orthotopic liver transplantation using small grafts. A way to avoid small-for-size syndrome?","volume":"29","author":"Scatton","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0082","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/SLA.0000000000001165","article-title":"A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept","volume":"262","author":"Line","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0083","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SLA.0000000000005726","article-title":"Auxilliary liver transplantation according to the RAPID procedure in noncirrhotic patients: technical aspects and early outcomes","volume":"277","author":"Settmacher","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0084","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181bdf8cf","article-title":"Hepatic metastases from neuroendocrine tumors with a \"thin slice\" pathological examination: they are many more than you think","volume":"251","author":"Elias","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2468-1253(21)00219-3","article-title":"Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines","volume":"6","author":"Bonney","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0086","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0087","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.hbpd.2023.08.007","article-title":"Liver transplantation as an alternative for treatment of neuroendocrine liver metastasis: appraisal of the current evidence","volume":"23","author":"M\u00fcller","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0088","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0089","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11912-022-01343-8","article-title":"Where are we now with liver transplantation in neuroendocrine neoplasms? The place of liver transplantation for grades 1 and 2 well-differentiated unresectable liver metastatic neuroendocrine tumours","volume":"25","author":"Shah","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11154-017-9439-7","article-title":"The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons","volume":"18","author":"Sposito","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0091","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/SLA.0000000000005663","article-title":"Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal","volume":"277","author":"Eshmuminov","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0092","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1477-2574.2010.00175.x","article-title":"Multimodal management of neuroendocrine liver metastases","volume":"12","author":"Frilling","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0093","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0094","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/bjs5.50278","article-title":"Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)","volume":"4","author":"Smedman","year":"2020","journal-title":"BJS Open"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0096","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","article-title":"Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?","volume":"261","author":"Dueland","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0097","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/ajt.15682","article-title":"Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis","volume":"20","author":"Dueland","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0098","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/bjs.10769","article-title":"Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma","volume":"105","author":"Dueland","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0099","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/bjs.10651","article-title":"Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases","volume":"105","author":"Grut","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/tri.13471","article-title":"Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study","volume":"32","author":"Smedman","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/bjs\/znac022","article-title":"Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases","volume":"109","author":"Bj\u00f8rnelv","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/bjs5.50116","article-title":"Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver","volume":"3","author":"Dueland","year":"2018","journal-title":"BJS Open"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hbpd.2023.12.002","article-title":"Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: advancing the therapeutic algorithm","volume":"23","author":"Rawashdeh","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.hpb.2023.05.360","article-title":"The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE","volume":"25","author":"Siriwardena","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0105","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/tri.13981","article-title":"Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score","volume":"34","author":"Lanari","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0106","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.3748\/wjg.v21.i39.11185","article-title":"Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review","volume":"21","author":"de'Angelis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0107","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1007\/s00268-012-1533-0","article-title":"Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation","volume":"36","author":"Hwang","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0108","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1245\/s10434-014-4273-6","article-title":"Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series","volume":"22","author":"Sapisochin","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0109","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.24742","article-title":"Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?","volume":"23","author":"Fernandez-Sevilla","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/lt.25191","article-title":"Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence","volume":"24","author":"Jung","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0111","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/TP.0000000000003802","article-title":"Postrecurrence survival after liver transplantation for liver metastases from neuroendocrine tumors","volume":"105","author":"Sposito","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0112","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1245\/s10434-013-3449-9","article-title":"Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"21","author":"Hagness","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0113","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/ajt.16448","article-title":"PD-1 inhibitor as bridge therapy to liver transplantation?","volume":"21","author":"Tabrizian","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0114","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0115","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.transproceed.2023.03.064","article-title":"Optimizing the safe washout period for liver transplantation following immune checkpoint inhibitors with atezolizumab, nivolumab, or pembrolizumab","volume":"55","author":"Kuo","year":"2023","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.eng.2022.07.007","article-title":"Immunosuppression and liver transplantation","volume":"21","author":"Lerut","year":"2023","journal-title":"Engineering"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0117","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1002\/cam4.5271","article-title":"Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients","volume":"12","author":"Bhat","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0118","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0b013e31819009c9","article-title":"Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study","volume":"248","author":"Lerut","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0119","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.hbpd.2019.05.006","article-title":"Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: a multicenter European experience","volume":"18","author":"Lai","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0120","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3390\/cancers12102791","article-title":"Novel model to predict HCC recurrence after liver transplantation obtained using deep learning: a multicenter study","volume":"12","author":"Nam","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0121","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/lt.26332","article-title":"The Toronto post liver transplantation hepatocellular carcinoma recurrence calculator: a machine learning approach","volume":"28","author":"Ivanics","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0122","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cac2.12468","article-title":"Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence","volume":"43","author":"Lai","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0123","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jhep.2014.01.022","article-title":"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on \"number of patients needed to transplant\" as measure of transplant benefit","volume":"60","author":"Vitale","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0124","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/lt.25492","article-title":"The intention-to-treat effect of bridging treatments in the setting of Milan criteria-in patients waiting for liver transplantation","volume":"25","author":"Lai","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.3112","article-title":"Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant","volume":"156","author":"Lai","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0126","article-title":"Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma","volume":"5","author":"Goudsmit","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0127","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"A multistep, consensus-based approach to organ allocation in liver transplantation: toward a \"blended principle model","volume":"15","author":"Cillo","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0128","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2020.08.015","article-title":"Liver transplantation for secondary liver tumours: the difficult balance between survival and recurrence","volume":"73","author":"Line","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.001_bib0129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2023.03.029","article-title":"Transplantation for metastatic liver disease","volume":"78","author":"Clift","year":"2023","journal-title":"J Hepatol"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:45:14Z","timestamp":1761493514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1499387223002394"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.12.001","relation":{},"ISSN":["1499-3872"],"issn-type":[{"type":"print","value":"1499-3872"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}